Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic  lupus erythematosus

Ghaydaa A Shehata1, Mohamed I Abdel-Kareem2, Abd ellah N Yassin4, Abdel Ahamid R El Adl31Department of Neurology, Faculty of Medicine, Assiut University, Assiut, Egypt; 2Department of Rheumatology, Physical Medicine and Rehabilitation Faculty of Medicine, 3Department of Internal Medicine, Faculty of...

Full description

Bibliographic Details
Main Authors: Ghaydaa A Shehata, Mohamed I Abdel-Kareem, Abd ellah N Yassin, et al
Format: Article
Language:English
Published: Dove Medical Press 2010-07-01
Series:Open Access Rheumatology : Research and Reviews
Online Access:http://www.dovepress.com/subclinical-cerebrovascular-cognitive-function-nbspand-mood-changes-in-a4769
id doaj-c07cf838639c47b8b86578c6130d5fd7
record_format Article
spelling doaj-c07cf838639c47b8b86578c6130d5fd72020-11-24T22:53:26ZengDove Medical PressOpen Access Rheumatology : Research and Reviews1179-156X2010-07-012010default1725Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic  lupus erythematosusGhaydaa A ShehataMohamed I Abdel-KareemAbd ellah N Yassinet alGhaydaa A Shehata1, Mohamed I Abdel-Kareem2, Abd ellah N Yassin4, Abdel Ahamid R El Adl31Department of Neurology, Faculty of Medicine, Assiut University, Assiut, Egypt; 2Department of Rheumatology, Physical Medicine and Rehabilitation Faculty of Medicine, 3Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Assiut, Egypt; 4Department of Diagnostic Radiology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt Objective: To estimate the prevalence of neuropsychiatric disorders, cerebral atherosclerosis in patients with systemic lupus erythematosus (SLE) and explore the relation between transcranial duplex findings of different intracranial vessels with neuropsychiatric affect, and Systemic lupus erythematosus disease activity index (SLEDAI).Methods: Twenty-six consecutive SLE patients were evaluated for neurological and psychiatric disorders. Another 26 subjects matched with respect to age, sex, education, and socioeconomic status formed the control group. SLE disease activity was assessed by the SLEDAI. For each participant, a complete medical history was obtained and clinical, laboratory, and neurophysiological examinations, magnetic resonance imaging of the brain, transcranial duplex for intracranial vessels, and psychometric evaluations were performed. For the psychometric evaluation, we used the Modified Mini-mental State Examination and Cognitive Assessment Scale Inventory to assess cognitive function, and Hamilton Depression Rating Scale and Hamilton Anxiety Scale to assess symptoms of depression and anxiety.Results: Anxiety in 65.4% is the most prevalent manifestation followed by depression in 57.7%, headache in 38.5%, peripheral neuropathy in 26.9%, seizures in 23.1%, psychosis in 19.2%, radiculopathy and dementia in 15.4% for each, myositis in 11.5%, and stroke in 7.7%. There was a significant increased mean velocity and decreased pulsatility index of most studied intracranial vessels in both patient groups than in the control group. There was significant negative correlation between SLEDAI and transcranial Doppler findings in the pulsatility index of medial circumflex artery and procoagulant activity.Conclusion: Neurological disorders, cognitive impairment, depression, anxiety, psychosis and cerebrovascular changes detected by transcranial Doppler ultrasound are common in SLE.Keywords: SLE, SLEDAI, cognitive function, depression, anxiety, neurological disorders, TCD, cerebrovascular changes http://www.dovepress.com/subclinical-cerebrovascular-cognitive-function-nbspand-mood-changes-in-a4769
collection DOAJ
language English
format Article
sources DOAJ
author Ghaydaa A Shehata
Mohamed I Abdel-Kareem
Abd ellah N Yassin
et al
spellingShingle Ghaydaa A Shehata
Mohamed I Abdel-Kareem
Abd ellah N Yassin
et al
Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic  lupus erythematosus
Open Access Rheumatology : Research and Reviews
author_facet Ghaydaa A Shehata
Mohamed I Abdel-Kareem
Abd ellah N Yassin
et al
author_sort Ghaydaa A Shehata
title Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic  lupus erythematosus
title_short Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic  lupus erythematosus
title_full Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic  lupus erythematosus
title_fullStr Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic  lupus erythematosus
title_full_unstemmed Subclinical cerebrovascular cognitive function, and mood changes in patients with systemic  lupus erythematosus
title_sort subclinical cerebrovascular cognitive function, and mood changes in patients with systemic  lupus erythematosus
publisher Dove Medical Press
series Open Access Rheumatology : Research and Reviews
issn 1179-156X
publishDate 2010-07-01
description Ghaydaa A Shehata1, Mohamed I Abdel-Kareem2, Abd ellah N Yassin4, Abdel Ahamid R El Adl31Department of Neurology, Faculty of Medicine, Assiut University, Assiut, Egypt; 2Department of Rheumatology, Physical Medicine and Rehabilitation Faculty of Medicine, 3Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Assiut, Egypt; 4Department of Diagnostic Radiology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt Objective: To estimate the prevalence of neuropsychiatric disorders, cerebral atherosclerosis in patients with systemic lupus erythematosus (SLE) and explore the relation between transcranial duplex findings of different intracranial vessels with neuropsychiatric affect, and Systemic lupus erythematosus disease activity index (SLEDAI).Methods: Twenty-six consecutive SLE patients were evaluated for neurological and psychiatric disorders. Another 26 subjects matched with respect to age, sex, education, and socioeconomic status formed the control group. SLE disease activity was assessed by the SLEDAI. For each participant, a complete medical history was obtained and clinical, laboratory, and neurophysiological examinations, magnetic resonance imaging of the brain, transcranial duplex for intracranial vessels, and psychometric evaluations were performed. For the psychometric evaluation, we used the Modified Mini-mental State Examination and Cognitive Assessment Scale Inventory to assess cognitive function, and Hamilton Depression Rating Scale and Hamilton Anxiety Scale to assess symptoms of depression and anxiety.Results: Anxiety in 65.4% is the most prevalent manifestation followed by depression in 57.7%, headache in 38.5%, peripheral neuropathy in 26.9%, seizures in 23.1%, psychosis in 19.2%, radiculopathy and dementia in 15.4% for each, myositis in 11.5%, and stroke in 7.7%. There was a significant increased mean velocity and decreased pulsatility index of most studied intracranial vessels in both patient groups than in the control group. There was significant negative correlation between SLEDAI and transcranial Doppler findings in the pulsatility index of medial circumflex artery and procoagulant activity.Conclusion: Neurological disorders, cognitive impairment, depression, anxiety, psychosis and cerebrovascular changes detected by transcranial Doppler ultrasound are common in SLE.Keywords: SLE, SLEDAI, cognitive function, depression, anxiety, neurological disorders, TCD, cerebrovascular changes
url http://www.dovepress.com/subclinical-cerebrovascular-cognitive-function-nbspand-mood-changes-in-a4769
work_keys_str_mv AT ghaydaaashehata subclinicalcerebrovascularcognitivefunctionampnbspandmoodchangesinpatientswithsystemicampnbsplupuserythematosus
AT mohamediabdelkareem subclinicalcerebrovascularcognitivefunctionampnbspandmoodchangesinpatientswithsystemicampnbsplupuserythematosus
AT abdellahnyassin subclinicalcerebrovascularcognitivefunctionampnbspandmoodchangesinpatientswithsystemicampnbsplupuserythematosus
AT etal subclinicalcerebrovascularcognitivefunctionampnbspandmoodchangesinpatientswithsystemicampnbsplupuserythematosus
_version_ 1725663530267443200